VIVO Cannabis Inc. announced the appointment of Andreas Sander as President, European Operations, and Managing Director of ABcann Germany GmbH, the company's German subsidiary. Mr. Sander will assume the position effective January 1, 2019. As VIVO's President, European Operations, Mr. Sander is expected to lead the Company's burgeoning German activities and oversee the expansion of its operations into multiple European markets. Mr. Sander has accumulated a wealth of leadership experience in the 25 years he has spent in the European pharmaceutical industry. He has held multiple VP and managing director roles with multinational pharmaceutical companies in Western and Eastern Europe, including executive positions at Boston Healthcare International, Sanofi Pasteur, ALK-Abelló and Wyeth Pharmaceuticals. His diverse expertise includes: operational leadership with full P&L responsibility in multiple countries and across various therapeutic areas; marketing strategy and sales execution in established markets; the European launch of multiple new products; the execution of European tender and compliance strategies; and a history of building high performance teams.